Neuca SA operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neuca SA with three other
drug stores in Europe:
Oriola KD Oyj
sales of 1.63 billion Euro [US$1.79 billion]
of which 73%
was Pharmaceutical Trade Sweden),
(5.91 billion Polish New Zlotys [US$1.50 billion]
of which 102%
was Wholesale), and
(8.46 billion Polish New Zlotys [US$2.15 billion]
of which 69%
was Wholesale Trade).
Neuca SA reported sales of 6.95 billion Polish New Zlotys (US$1.77 billion)
December of 2015.
increase of 5.7%
versus 2014, when the company's sales were 6.57 billion Polish New Zlotys.
This was the third consecutive year of growth at Neuca SA.
Sales of Medical Centers saw an increase
that was more than double the company's growth rate: sales were up
581.5% in 2015, from
3.39 million Polish New Zlotys to 23.10 million Polish New Zlotys.
Neuca SA also saw significant increases in sales in
Marketing and Distribution Services (up 154.4% to 3.16 million Polish New Zlotys)
Own Medicines (up 333.3% to 247,000.00 Polish New Zlotys)
Not all segments of Neuca SA experienced an increase in sales in 2015:
sales of It Service fell 2.1% to 5.86 million Polish New Zlotys.
(However, this segment's sales were only a very small portion of the company's overall sales).